What's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge?

Benzinga_recent_news01-14

Gelteq Ltd. (NASDAQ:GELS) shares jumped 69.25% in after-hours trading to $1.41 on Tuesday after the company reported positive preclinical results for its cannabinoid oral gel delivery platform. Check ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2603366655?lang=en_US&edition=fundamental","thumbnail":"https://cdn.benzinga.com/files/images/story/2026/01/13/Stock-Market-Or-Forex-Trading-Graph-In-F.jpeg?optimize=medium&dpr=2&auto=webp&width=120","is_english":true,"pubTime":"2026-01-14 12:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2603366655","market":"hk","top_or_hot":-1,"title":"What's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge?","media":"Benzinga_recent_news","content":"<div>\n<p>Gelteq Ltd. (NASDAQ:GELS) shares jumped 69.25% in after-hours trading to $1.41 on Tuesday after the company reported positive preclinical results for its cannabinoid oral gel delivery platform.\nCheck ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/01/49896114/whats-driving-gelteq-ltd-s-gels-over-69-after-hours-surge\">Source Link</a>\n\n</div>\n","source":"benzinga_recent_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat's Driving Gelteq Ltd.'s (GELS) Over 69% After-Hours Surge?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-01-14 12:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/markets/equities/26/01/49896114/whats-driving-gelteq-ltd-s-gels-over-69-after-hours-surge><strong>Benzinga_recent_news</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Gelteq Ltd. (NASDAQ:GELS) shares jumped 69.25% in after-hours trading to $1.41 on Tuesday after the company reported positive preclinical results for its cannabinoid oral gel delivery platform.\nCheck ...</p>\n\n<a href=\"https://www.benzinga.com/markets/equities/26/01/49896114/whats-driving-gelteq-ltd-s-gels-over-69-after-hours-surge\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.benzinga.com/markets/equities/26/01/49896114/whats-driving-gelteq-ltd-s-gels-over-69-after-hours-surge","article_id":"2603366655","we_media_id":null,"thumbnails":["https://cdn.benzinga.com/files/images/story/2026/01/13/Stock-Market-Or-Forex-Trading-Graph-In-F.jpeg?optimize=medium&dpr=2&auto=webp&width=120"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/markets/equities/26/01/49896114/whats-driving-gelteq-ltd-s-gels-over-69-after-hours-surge","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2603366655","pubTimestamp":1768363260,"columns":[],"sourceInfo":{"source_id":"benzinga_recent_news","name":"Benzinga"},"weMediaInfo":null,"summary":"Shares of Gelteq Ltd. jumped 69.25% in after-hours trading following the company's announcement of encouraging preclinical data for its cannabinoid oral gel platform.","collect":0,"end_time":0,"defaultTopTitle":"benzinga.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","RSI":"Rush Street Interactive, Inc.","BK4150":"赌场与赌博","GELS":"Gelteq"},"translate_title":"是什么推动Gelteq Ltd.(GELS)盘后股价飙升超过69%？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"GELS":1.5,"RSI":1},"content_text":"Gelteq Ltd. (NASDAQ:GELS) shares jumped 69.25% in after-hours trading to $1.41 on Tuesday after the company reported positive preclinical results for its cannabinoid oral gel delivery platform.\nCheck out the current price of GELS stock here.\nThe Melbourne-based company reported that its proprietary oral gel platform achieved a greater than 22% increase in the bioavailability of cannabidiol compared with an existing Food and Drug Administration-approved oil-based product, according to a Tuesday announcement.\nAccording to Gelteq, the formulation demonstrated higher peak exposure despite containing lower cannabidiol concentrations.\nThe clinical-stage company stated that the results create a pathway for market launch through Australia’s Special Access Scheme, which allows authorized healthcare practitioners to prescribe medicinal cannabis products without undergoing the full Therapeutic Goods Administration approval process.\nGelteq said this could enable earlier patient access and faster market entry.\nGelteq also stated the study results could allow partnerships with medicinal cannabis companies without additional studies, potentially speeding up licensing, white-label manufacturing, and co-development of cannabinoid products, including CBD, THC, and combination formulations.\nThe biotechnology company has a Relative Strength Index (RSI) of 41.92.\nGelteq has a market capitalization of $8.95 million, with shares trading between a 52-week high of $4.11 and a 52-week low of $0.67.\nThe stock is currently down 58.76% over the past 12 months, reflecting a longer-term bearish trend, though recent gains suggest investors should watch for potential signs of recovery.\nPrice Action: According to Benzinga Pro data, GELS closed at $0.83 on Tuesday, up 6.44%.\nThe stock is currently trading at about 4.65% of its 52-week range, near its yearly low, suggesting that despite short-term bullish signals, the longer-term trend remains weak.\nBenzinga’s Edge Stock Rankings indicates GELS stock has a negative price trend across all time frames. Track the performance of other players in this segment.\nPhoto: Sittipong Phokawattana from Shutterstock\nDisclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2603366655","isCrawlerRequest":true}